Phase I study of 21 days continuous infusion with vindesine.
de Vries
E G
EG
Department of Internal Medicine, University Hospital Groningen, The Netherlands.
Smit
E F
EF
Vendrig
D E
DE
Holthuis
J J
JJ
Mulder
N H
NH
D000328:Adult; D000368:Aged; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007260:Infusion Pumps; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000139:chemically induced; D014751:Vindesine / Q000008:administration & dosage* / Q000009:adverse effects
D014751:Vindesine